You’ve probably all heard about Imlifidase, the new miracle drug which is capable of bringing down IgG from normal levels to virtually zero in a matter of hours. Is this going to be a revolution in transplantation, particularly for allosensitized patients? You can get the answers to these questions by listening to our podcast with Rainer Oberbauer on Imlifidase. You can expect to hear how the drug works, how well it performs, particularly in allosensitized individuals, and what are the tips and tricks for using this drug. 

In this ANCA vasculitis episode we will be talking to Vladimir Tesar about the new KDIGO guidelines – what are the novelties, how we should treat ANCA vasculitis patients in this day and age, some difficult cases will be discussed, plasma exchange, rituximab, and much, much more.

In this episode, we explore the latest insights on treating arterial hypertension in 2025. With updates from the European Society of Hypertension and the European Society of Cardiology, the standards for blood pressure management are evolving rapidly.
Joining us is Pantelis Sarafidis from Aristotle University of Thessaloniki. What’s new in these guidelines? How do they redefine hypertension management, particularly for patients with kidney disease? And what does the treatment algorithm look like for 2025 and beyond?

In today’s episode, we’re focusing on a crucial yet often under-discussed subject: the role of vaccination in chronic kidney disease. Patients with CKD are at a markedly increased risk of infections, a vulnerability compounded by factors like impaired immunity, dialysis, and immunosuppressive therapies. Vaccination, therefore, plays an indispensable role in safeguarding their health. In this episode, we’ll examine which vaccines are recommended for CKD patients. We’ll also address the challenges of ensuring vaccine efficacy in immunosuppressed patients and explore how vaccination practices should be tailored across various CKD stages. Our guest is Nina Babel from the University of Bochum in Germany, a renowned expert on this subject.
This episode combines scientific insights with practical advice to equip you with the knowledge in order to enhance patient care. Check it out!

Renal pathology is about much more than diagnosis, it’s about decoding the mechanisms of diseases like glomerular and tubulointerstitial disorders to shape more effective, personalized treatments. In this episode, we’ll dive into the methodologies behind renal biopsies, and the critical role they play in guiding treatment strategies. Looking ahead, we’ll also discuss the future of renal pathology and its impact on the care we provide. Joining us is Ingeborg Bajema from the University of Groningen in the Netherlands. A renowned expert in the field, she’ll share her perspective on current biopsy techniques, the changes we’ve seen in renal pathology, and the exciting possibilities for the years ahead. 
Stay tuned, and let’s uncover the intricate connections between renal pathology and better patient care.

How do I start a research project? How do I join a research team? How does one get financing for research projects? How do I understand medical publishing and how to thrive in it? We've all been there, my friend. Andreas Kronbichler has been there too. As our next guest of our research related, A Pinch of Salt podcast, he will try to answer these questions. And I believe you'll find them informative. Check it out.